Lantheus Holdings (LNTH) Accumulated Expenses (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Accumulated Expenses of $286.5 million for Q1 2026, up 41.56% year-over-year from $202.4 million in Q1 2025, and up 7.18% quarter-over-quarter from $267.3 million in Q4 2025.
Lantheus Holdings (LNTH) Accumulated Expenses (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Accumulated Expenses for 13 consecutive years, with $286.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accumulated Expenses rose 41.56% year-over-year to $286.5 million; the TTM figure through Mar 2026 stood at $286.5 million (up 41.56% YoY), while the FY2025 annual figure was $267.3 million, up 453.85% from the prior year.
- Accumulated Expenses rose to $286.5 million in Q1 2026 per LNTH's latest filing, from $267.3 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $286.5 million in Q1 2026 and bottomed at $48.3 million in Q4 2024.
- Historically, Accumulated Expenses has averaged $178.7 million across 5 years, with a median of $183.8 million in 2022.
- Annual changes were most pronounced in 2024 — Accumulated Expenses slumped 66.79% — and 2025, when it soared 453.85%.
- Lantheus Holdings' Accumulated Expenses stood at $127.1 million in 2022, then grew by 14.36% to $145.3 million in 2023, then slumped by 66.79% to $48.3 million in 2024, then jumped by 453.85% to $267.3 million in 2025, then advanced by 7.18% to $286.5 million in 2026.
- Business Quant data shows LNTH's Accumulated Expenses at $286.5 million in Q1 2026, $267.3 million in Q4 2025, and $251.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Lantheus Holdings | 6.52 Bn | 5.93 Bn | 241.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 286.87 Mn |
| Mar 31, 2026 | 286.49 Mn |
| Dec 31, 2025 | 267.31 Mn |
| Sep 30, 2025 | 251.11 Mn |
| Jun 30, 2025 | 208.60 Mn |
| Mar 31, 2025 | 202.38 Mn |
| Dec 31, 2024 | 48.26 Mn |
| Sep 30, 2024 | 174.45 Mn |
| Jun 30, 2024 | 212.64 Mn |
| Mar 31, 2024 | 198.94 Mn |
| Dec 31, 2023 | 145.34 Mn |
| Sep 30, 2023 | 138.82 Mn |
| Jun 30, 2023 | 114.80 Mn |
| Mar 31, 2023 | 145.47 Mn |
| Dec 31, 2022 | 127.08 Mn |
| Sep 30, 2022 | 190.48 Mn |
| Jun 30, 2022 | 183.80 Mn |
| Mar 31, 2022 | 142.40 Mn |
| Dec 31, 2021 | 58.07 Mn |
| Sep 30, 2021 | 46.04 Mn |